Cargando…

Testosterone and weight loss: the evidence

PURPOSE OF REVIEW: The purpose of this article is to examine the contemporary data linking testosterone therapy in overweight and obese men with testosterone deficiency to increased lean body mass, decreased fat mass, improvement in overall body composition and sustained weight loss. This is of para...

Descripción completa

Detalles Bibliográficos
Autor principal:	Traish, Abdulmaged M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott, Williams & Wilkins 2014
Materias:	OBESITY AND NUTRITION: Edited by Caroline Apovian
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154787/ https://www.ncbi.nlm.nih.gov/pubmed/25105998 http://dx.doi.org/10.1097/MED.0000000000000086

Ejemplares similares

Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction
por: Bays, Harold
Publicado: (2014)

MON-091 Profound and Sustained Weight Loss in Men With Hypogonadism and Obesity Receiving Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU): 10-Year Data from a Registry Study in a Urological Setting
por: Haider, Karim, et al.
Publicado: (2019)

Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?
por: Traish, Abdulmaged
Publicado: (2016)

Erratum: Correction of the references for Figures. Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?
por: Traish, Abdulmaged
Publicado: (2017)

Letter to the editor: Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer
por: Morgentaler, Abraham, et al.
Publicado: (2020)

Impact of Testosterone Deficiency and Testosterone Therapy on Lower Urinary Tract Symptoms in Men with Metabolic Syndrome
por: Traish, Abdulmaged M., et al.
Publicado: (2018)

Does IRISIN Have a BRITE Future as a Therapeutic Agent in Humans?
por: Irving, Brian A., et al.
Publicado: (2014)

Hyperinsulinemia: a Cause of Obesity?
por: Erion, Karel A., et al.
Publicado: (2017)

Weight Loss Trajectory Patterns and Short-Term Prediction in a Weight Management Program
por: Zhou, Bingjie, et al.
Publicado: (2022)

Motivating Weight Loss Among Black Adults in Relationships: Recommendations for Weight Loss Interventions
por: Alick, Candice L., et al.
Publicado: (2022)

Healthy Habits Associated with Successful Weight Loss Maintenance on a Commercial Program
por: Kiel, Jessica, et al.
Publicado: (2022)

Successful Maintenance after Weight Loss on a Commercial Program: Habits and Benefits Among Coaches
por: Coleman, Christopher, et al.
Publicado: (2022)

SUN-222 Testosterone Treatment in Men with Classical vs. Functional Hypogonadism: A 9-Year Registry
por: Zitzmann, Michael, et al.
Publicado: (2019)

Osteoarthritis, obesity and weight loss: evidence, hypotheses and horizons – a scoping review
por: Bliddal, H, et al.
Publicado: (2014)

Evaluation of the Comparative Validity of a Smartphone Weight-Loss Trial App with a 24-Hour Diet Recall
por: Kalam, Faiza, et al.
Publicado: (2022)

Progressive Improvement of T-Scores in Men with Osteoporosis and Subnormal Serum Testosterone Levels upon Treatment with Testosterone over Six Years
por: Haider, Ahmad, et al.
Publicado: (2014)

SUN-226 Improvements In Quality Of Life In Men With Hypogonadism Under Long-term Testosterone Therapy (TTh) With Testosterone Undecanoate Injections (TU): Experience From 6,500 Patient-years Ina Registry Study Ina Urological Setting
por: Haider, Karim, et al.
Publicado: (2019)

Recognizing the True Value of Testosterone Therapy in Health Care
por: Morgentaler, Abraham, et al.
Publicado: (2022)

SAT-533 Men with Hypogonadism and Osteoporosis Benefit from Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU) Regardless of Co-Medication with Bisphosphonates: 10-Year Data from a Controlled Registry Study in a Urological Setting
por: Haider, Ahmad, et al.
Publicado: (2019)

SUN-055 Reduction of Mortality and Major Adverse Cardiovascular Events (MACE) in Men with Hypogonadism Treated with Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU): 10-Year Data from a Registry Study in a Urological Setting
por: Saad, Farid, et al.
Publicado: (2019)

The Effects of a Hypocaloric Diet Containing Peanuts on Weight Loss, Glycemic Control and Blood Pressure: A 6-Month Randomized Controlled Trial
por: Petersen, Kristina, et al.
Publicado: (2022)

OR21-2 Lipid Profiles Improve in Men With Hypogonadism and Pre-existing Cardiovascular Disease Under Long-term Testosterone Therapy (TTh) With Testosterone Undecanoate Injections (TU): 10-year Data From a Controlled Registry Study in a Urological Setting
por: Haider, Ahmad, et al.
Publicado: (2019)

Early Weight Loss with Liraglutide 3.0 mg Predicts 1‐Year Weight Loss and is Associated with Improvements in Clinical Markers
por: Fujioka, Ken, et al.
Publicado: (2016)

Obesity in the Elderly Diabetic Patient: Is weight loss beneficial? No
por: Kyrou, Ioannis, et al.
Publicado: (2009)

Are fatty nuts a weighty concern? A systematic review and meta‐analysis and dose–response meta‐regression of prospective cohorts and randomized controlled trials
por: Nishi, Stephanie K., et al.
Publicado: (2021)

A systematic review of the relationship between weight status perceptions and weight loss attempts, strategies, behaviours and outcomes
por: Haynes, A., et al.
Publicado: (2017)

SUN-083 Hypertension and Hemodynamic Parameters in Men with Hypogonadism Improve Under Long-Term Treatment with Testosterone Undecanoate Injections (TU) Compared to Untreated Hypogonadal Control Patients
por: Saad, Farid, et al.
Publicado: (2019)

Consequences of obesity and weight loss: a devil's advocate position
por: Brown, R E, et al.
Publicado: (2015)

A Scalable, Weight Management Program Tailored for Adults with Type 2 Diabetes: Effects on Glycemic Control, Weight, Hunger, and Quality of Life
por: Apolzan, John, et al.
Publicado: (2022)

Abstract #1318481: Psychological Impact of COVID-19 Pandemic on Waitlisted Prebariatric Surgery Patients in Saudi Arabia: A Cross-Sectional Study
por: Turkistani, Haneen, et al.
Publicado: (2022)

First, Do No Harm: Understanding Primary Care Providers’ Perception of Risks Associated With Discussing Weight With Pediatric Patients
por: Loth, Katie A., et al.
Publicado: (2021)

Pediatrician’s Beliefs and Practices Around Rapid Infant Weight Gain: A Qualitative Study
por: Pesch, Megan H., et al.
Publicado: (2021)

A systematic review and meta‐analysis of the effectiveness of meal replacements for weight loss
por: Astbury, Nerys M., et al.
Publicado: (2019)

Effect of dose of behavioral weight loss treatment on glycemic control in adults with prediabetes
por: Bauman, Viviana, et al.
Publicado: (2019)

Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It's Time to Sound the Alarm
por: Traish, Abdulmaged M.
Publicado: (2020)

Sex steroids and COVID-19 mortality in women
por: Traish, Abdulmaged M.
Publicado: (2021)

Cognitive and behavioural strategies for self‐directed weight loss: systematic review of qualitative studies
por: Hartmann‐Boyce, J., et al.
Publicado: (2017)

Diet and Gastrointestinal Bypass–Induced Weight Loss: The Roles of Ghrelin and Peptide YY
por: Chandarana, Keval, et al.
Publicado: (2011)

Metabolic recovery after weight loss surgery is reflected in serum microRNAs
por: Sangiao-Alvarellos, Susana, et al.
Publicado: (2020)

Nutrition Interventions for Weight Gain and Body Composition Changes in Menopausal Women: A Review
por: McClain, Kelley, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jh4f8id980v467ngq6ne26nfrj